One Hundred Thirteenth Congress of the United States of America
2d Session
Begun and held at the City of Washington on Friday, the third day of January, two thousand and fourteen
S. 2917
IN THE SENATE OF THE UNITED STATES
AN ACT
To expand the program of priority review to encourage treatments for tropical diseases.
Short title
This Act may be cited as the
Adding Ebola to the FDA Priority Review Voucher Program Act
.
Priority review to encourage treatments for tropical diseases
Section 524 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360n ) is amended—
in subsection (a)(3)—
by redesignating subparagraph (Q) as subparagraph (R);
by inserting after subparagraph (P) the following:
Filoviruses.
; and
in subparagraph (R), as so redesignated, by striking regulation by
and inserting order of
; and
in subsection (b)—
in paragraph (2), by adding There is no limit on the number of times a priority review voucher may be transferred before such
voucher is used.
after the period at the end; and
in paragraph (4), by striking 365 days
and inserting 90 days
.
Speaker of the House of Representatives
Vice President of the United States and President of the Senate
